Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on September 18, 2026

Sep. 18, 2026

DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Shares

Indeterminate EIN Presswire

Sep. 18, 2026

Lakewood-Amedex Announces IRB Approval to Initiate Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers

Indeterminate EIN Presswire

Sep. 18, 2026

Michael Feinstein & Dr. Kendra Siler Launch World Premiere, Music Forms Memories, $44.9M Grant, Liza Minnelli Ambassador

Indeterminate EIN Presswire

Sep. 18, 2026

Pyure Wins Silver in 2026 McKnight’s Excellence in Technology Awards

Indeterminate EIN Presswire

Sep. 18, 2026

Refresh Examines How AI and Healthy Aging Are Reshaping Aesthetics in 2026

Indeterminate EIN Presswire

Sep. 18, 2026

Gonstead Chiropractic of Florida Named 2026 Best of Florida Award Winner

Indeterminate EIN Presswire

Sep. 18, 2026

Adaptive Mobility at Home: How VELA Chairs Support Safe Stroke Recovery

Indeterminate EIN Presswire

Sep. 18, 2026

RACHEL BLUMBERG, PRESIDENT & CEO OF SINAI RESIDENCES, NAMED FINALIST IN 2026 STEVIE® AWARDS FOR WOMEN IN BUSINESS

Indeterminate EIN Presswire

Sep. 18, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Johns Hopkins USFHP is One of the Highest-Rated Health Plans in the Nation

Indeterminate GlobeNewswire

Sep. 18, 2026

VELA Medical Raises Awareness of New Federal Accessibility Rules for Medical Equipment

Indeterminate EIN Presswire

Sep. 18, 2026

New Teva Study Identifies the Attributes that Healthcare Providers Prioritize when Selecting a Treatment for Tardive Dyskinesia in Older Patients

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Highlights New Real-World Data Showing UZEDY® (risperidone) Outperforms Other Long-Acting Injectables in Keeping Schizophrenia Patients on Treatment, While Reducing Emergency Care and Healthcare Costs

Indeterminate GlobeNewswire

Sep. 18, 2026

Teva Announces New Olanzapine LAI (TEV-'749) Post Hoc Data Highlighting High Rates of Stabilization and Long-Term Efficacy as Once-Monthly Subcutaneous Injectable for the Treatment of Schizophrenia in Adults

Indeterminate GlobeNewswire

Sep. 18, 2026

NurExone Expands U.S. Engagement Across Four Major Boston Life Sciences Events and Provides Corporate Update

Indeterminate GlobeNewswire

Sep. 18, 2026

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Sep. 18, 2026

Amneal Announces FDA Approval and Launch of Lanreotide Injection

Indeterminate GlobeNewswire

Sep. 18, 2026

Pemi Named Best Perimenopause Supplement Brand of 2026

Indeterminate GlobeNewswire